Total Funding
86
50
Total FundingPost-IPO Equity raised
Growth Score
-10 pts
Heat Score
-36 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
30501
G2GBIO is a biotechnology firm that specializes in the development of long-acting injectable medications for various diseases.
- Heeyong Lee: CEO & Founder
About the Company
G2GBIO is a biotechnology company that develops pharmaceutical products. The firm specializes in the development of long-acting injectable medications. The organization utilizes a specific microsphere drug delivery system to create its pharmaceutical formulations. This physical technology involves the mixture of active pharmaceutical ingredients
with biodegradable polymers. The chemical process controls the release rate of the drug within the human body over an extended period. The research pipeline includes candidate treatments for Alzheimer's disease, type 2 diabetes, and post-operative pain.
